ExodusPoint Capital Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-17,690
| Closed | -$246K | – | 1589 |
|
2024
Q1 | $246K | Buy |
+17,690
| New | +$246K | ﹤0.01% | 1186 |
|
2023
Q3 | – | Sell |
-6,316
| Closed | -$34K | – | 1834 |
|
2023
Q2 | $34K | Buy |
+6,316
| New | +$34K | ﹤0.01% | 1695 |
|
2022
Q4 | – | Sell |
-4,462
| Closed | -$92K | – | 1799 |
|
2022
Q3 | $92K | Buy |
+4,462
| New | +$92K | ﹤0.01% | 1720 |
|
2022
Q2 | – | Sell |
-5,187
| Closed | -$223K | – | 2101 |
|
2022
Q1 | $223K | Sell |
5,187
-2,767
| -35% | -$119K | ﹤0.01% | 1807 |
|
2021
Q4 | $476K | Buy |
+7,954
| New | +$476K | ﹤0.01% | 1410 |
|
2021
Q3 | – | Sell |
-5,711
| Closed | -$635K | – | 2288 |
|
2021
Q2 | $635K | Buy |
5,711
+3,094
| +118% | +$344K | 0.01% | 1164 |
|
2021
Q1 | $291K | Buy |
2,617
+96
| +4% | +$10.7K | ﹤0.01% | 1651 |
|
2020
Q4 | $268K | Buy |
+2,521
| New | +$268K | ﹤0.01% | 1521 |
|